Analysis of Metastatic-Related Gene Expression in Gastric Cancer by Low-Density cDNA Microarrays

References

1. ↵
   1. Sun XJ,
   2. Sun KL,
   3. Fu H, et al

   . The relationship between correlated expression of S100A4, nm23Hl and lymph node metastasis in gastric cancer. National Medical Journal of China (Chinese). 2001;81:59–60.

   OpenUrl
2. ↵
   1. Endo K,
   2. Maejara U,
   3. Baba H, et al

   . Heparanase gene expression and metastatic potential in human gastric cancer. Anticancer Res. 2001;21:3365–3369.

   OpenUrlPubMed
3. ↵
   1. Liu XP,
   2. Kawauchi S,
   3. Oga A, et al

   . Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma. Jpn J Cancer Res. 2002;93:291–295.

   OpenUrlCrossRefWeb of Science
4. 1. Amioka T,
   2. Kitadai Y,
   3. Tanaka S, et al

   . Vascular endothelial growth factor -C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer. 2002;38:1413–1419.

   OpenUrlCrossRefPubMedWeb of Science
5. 1. Huang BJ,
   2. Zhao YJ,
   3. Xu HM, et al

   . Significance of hRadl7 mRNA expression in human gastric cancer. Chin J Oncol. 2003;25:160–162.

   OpenUrl
6. 1. Weeks BH,
   2. He W,
   3. Olson KL, et al

   . Inducible expression of transforming growth factor betal in papillomas causes rapid metastasis. Cancer Res. 2001;61:7435–7443.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Hara H,
   2. Yamashita K,
   3. Shinada J, et al

   . Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer. Lung Cancer. 2001;34:219–226.

   OpenUrlPubMedWeb of Science
8. 1. Dai DQ,
   2. Chen JQ,
   3. Xu HM. et al

   . The clinical significance of E -cadherin and alpha -catenin expression in human gastric cancer. Chin J Oncol. 2001;23:35–38.

   OpenUrl
9. ↵
   1. Muneyuki T,
   2. Watanabe M,
   3. Yamanaka M, et al

   . KAIl/ CD82 expression as a prognosic factor in sporadic colorectal cancer. Anticancer Res. 2001;21:3581–3587.

   OpenUrlPubMed
10. ↵
    1. Huang BJ,
    2. Zhao YJ,
    3. Xu HM, et al

    . Optimization of cDNA microarray fabrication. Hereditas (Chinese). 2003;25:591–595.

    OpenUrl
11. ↵
    1. Zhao YJ,
    2. Huang BJ,
    3. Xu HM, et al

    . Optimization of low-density cDNA microarray. Life Science Research (Chinese). 2004;8:322–328.

    OpenUrl
12. ↵
    1. Wilson WJ,
    2. Strout CL,
    3. DeSantis TZ, et al

    . Sequence-specific identification of 18 pathogenic microorganisms using microarray technology. Mol Cell Probes. 2002;16:119–127.

    OpenUrlCrossRefPubMedWeb of Science
13. 1. Wen WH,
    2. Bernstein L,
    3. Lescallett J, et al

    . Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis. Cancer Res. 2000;60:2716–2722.

    OpenUrlAbstract/FREE Full Text
14. 1. Zhou Y,
    2. Gwadry FG,
    3. Reinhold WC, et al

    . Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. Cancer Res. 2002;62:1688–1695.

    OpenUrlAbstract/FREE Full Text
15. 1. Xu J,
    2. Stolk JA,
    3. Zhang X et al

    . Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 2000;60:1677–1682.

    OpenUrlAbstract/FREE Full Text
16. ↵
    1. van’t Veer LJ,
    2. Dai H,
    3. van de Vijver MJ, et al

    . Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530–536.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Amatschek S,
    2. Koenig U,
    3. Auer H, et al

    . Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res. 2004;64:844–856.

    OpenUrlAbstract/FREE Full Text
18. 1. Li M,
    2. Lin YM,
    3. Hasegawa S, et al

    . Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol. 2004;24:305–312.

    OpenUrlPubMedWeb of Science
19. ↵
    1. Hasegawa S,
    2. Furukawa Y,
    3. Li M, et al

    . Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res. 2002;62:7012–7017.

    OpenUrlAbstract/FREE Full Text
20. ↵
    1. Kimura K,
    2. Endo Y,
    3. Yonemura Y, et al

    . Clinical significance of SI00A4 and E -cadherin -related adhesion molecules in non-small cell lung cancer. Int J Oncol. 2000;16:1125–1131.

    OpenUrlPubMedWeb of Science
21. ↵
    1. Nowak J,
    2. Januszkiewicz D,
    3. Lewandowski K, et al

    . Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients. Eur J Gastroenterol Hepatol. 2003;15:75–80.

    OpenUrlCrossRefPubMed
22. ↵
    1. Dong JT,
    2. Lamb PW,
    3. Rinker-Schaeffer CW, et al

    . KAIl, a metastasis suppressor gene for prostate cancer on human chromosome llpll.2. Science. 1995;268:884–886.

    OpenUrlAbstract/FREE Full Text
23. ↵
    1. Yang X,
    2. Wei LL,
    3. Tang C, et al

    . Overexpression of KAIl suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res. 2001;61:5284–5288.

    OpenUrlAbstract/FREE Full Text
24. ↵
    1. Maurer CA,
    2. Gräber HU,
    3. Friess H, et al

    . Reduced expression of the metastasis suppressor gene KAIl in advanced colon cancer and its métastasés. Surgery. 1999;126:869–880.

    OpenUrlPubMedWeb of Science
25. ↵
    1. Shimizu D,
    2. Ishikawa T,
    3. Ichikawa Y, et al

    . Current progress in the prediction of chemosensitivity for breast cancer. Breast Cancer. 2004;11:42–48.

    OpenUrlPubMed
26. ↵
    1. Kim B,
    2. Bang S,
    3. Lee S, et al

    . Expression profiling and subtype-specific expression of stomach cancer. Cancer Res. 2003;63:8248–8255.

    OpenUrlAbstract/FREE Full Text